Market Tracker

03/23 7:57am ET

TESARO Inc (NASDAQ:TSRO)

155.78
Delayed Data
As of Mar 22
 +6.11 / +4.08%
Today’s Change
36.68
Today|||52-Week Range
192.94
+15.84%
Year-to-Date
Better Buy: Myriad Genetics, Inc. vs. Opko Health, Inc.
Mar 11 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close149.67
Today’s open149.64
Day’s range146.27 - 156.04
Volume733,036
Average volume (3 months)1,011,867
Market cap$8.4B
Dividend yield--
Data as of 03/22/2017

Growth & Valuation

Earnings growth (last year)-27.43%
Earnings growth (this year)+3.84%
Earnings growth (next 5 years)+152.82%
Revenue growth (last year)+14,039.75%
P/E ratioNM
Price/Sales142.97
Price/Book13.67

Competitors

 Today’s
change
Today’s
% change
JAZZJazz Pharmaceuticals...-0.61-0.43%
SGENSeattle Genetics Inc+1.08+1.74%
ALKSAlkermes Plc+2.07+3.61%
PRGOPerrigo Company PLC+0.29+0.43%
Data as of 03/22/2017

Financials

Next reporting dateMay 4, 2017
EPS forecast (this quarter)-$2.17
Annual revenue (last year)$44.8M
Annual profit (last year)-$387.5M
Net profit margin-864.45%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Lonnie Moulder
President, Chief Operating Officer &
Director
Mary Lynne Hedley
Corporate headquarters
Waltham, Massachusetts

Forecasts